Zurich Cantonal Bank’s CONMED CNMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $300K | Hold |
9,166
| – | – | ﹤0.01% | 2183 |
|
|
2026
Q1 | $324K | Buy |
+9,166
| New | +$373K | ﹤0.01% | 2060 |
|
|
2025
Q4 | – | Sell |
-7,869
| Closed | -$342K | – | 2769 |
|
|
2025
Q3 | $370K | Hold |
7,869
| – | – | ﹤0.01% | 1891 |
|
|
2025
Q2 | $410K | Hold |
7,869
| – | – | ﹤0.01% | 1776 |
|
|
2025
Q1 | $475K | Hold |
7,869
| – | – | ﹤0.01% | 1631 |
|
|
2024
Q4 | $539K | Buy |
7,869
+1,057
| +16% | +$73.7K | ﹤0.01% | 1585 |
|
|
2024
Q3 | $490K | Hold |
6,812
| – | – | ﹤0.01% | 1573 |
|
|
2024
Q2 | $472K | Hold |
6,812
| – | – | ﹤0.01% | 1523 |
|
|
2024
Q1 | $546K | Hold |
6,812
| – | – | ﹤0.01% | 1413 |
|
|
2023
Q4 | $746K | Buy |
6,812
+1,048
| +18% | +$108K | ﹤0.01% | 1233 |
|
|
2023
Q3 | $581K | Buy |
5,764
+494
| +9% | +$56.8K | ﹤0.01% | 1304 |
|
|
2023
Q2 | $716K | Buy |
5,270
+679
| +15% | +$82.9K | ﹤0.01% | 1137 |
|
|
2023
Q1 | $477K | Hold |
4,591
| – | – | ﹤0.01% | 1312 |
|
|
2022
Q4 | $407K | Buy |
4,591
+816
| +22% | +$67.7K | ﹤0.01% | 1374 |
|
|
2022
Q3 | $303K | Hold |
3,775
| – | – | ﹤0.01% | 1506 |
|
|
2022
Q2 | $361K | Hold |
3,775
| – | – | ﹤0.01% | 1425 |
|
|
2022
Q1 | $561K | Hold |
3,775
| – | – | ﹤0.01% | 1276 |
|
|
2021
Q4 | $535K | Buy |
3,775
+857
| +29% | +$121K | ﹤0.01% | 1393 |
|
|
2021
Q3 | $382K | Hold |
2,918
| – | – | ﹤0.01% | 1474 |
|
|
2021
Q2 | $401K | Hold |
2,918
| – | – | ﹤0.01% | 1363 |
|
|
2021
Q1 | $381K | Sell |
2,918
-757
| -21% | -$91.1K | ﹤0.01% | 1392 |
|
|
2020
Q4 | $412K | Buy |
3,675
+399
| +12% | +$37.8K | ﹤0.01% | 1389 |
|
|
2020
Q3 | $258K | Hold |
3,276
| – | – | ﹤0.01% | 1417 |
|
|
2020
Q2 | $236K | Buy |
3,276
+781
| +31% | +$54.3K | ﹤0.01% | 1421 |
|
|
2020
Q1 | $143K | Buy |
2,495
+364
| +17% | +$33.6K | ﹤0.01% | 1386 |
|
|
2019
Q4 | $238K | Hold |
2,131
| – | – | ﹤0.01% | 1242 |
|
|
2019
Q3 | $205K | Hold |
2,131
| – | – | ﹤0.01% | 1232 |
|
|
2019
Q2 | $182K | Buy |
2,131
+744
| +54% | +$61.2K | ﹤0.01% | 1281 |
|
|
2019
Q1 | $115K | Sell |
1,387
-477
| -26% | -$34.7K | ﹤0.01% | 1494 |
|
|
2018
Q4 | $120K | Hold |
1,864
| – | – | ﹤0.01% | 1497 |
|
|
2018
Q3 | $148K | Buy |
1,864
+237
| +15% | +$18.3K | ﹤0.01% | 1477 |
|
|
2018
Q2 | $119K | Sell |
1,627
-299
| -16% | -$20.3K | ﹤0.01% | 1549 |
|
|
2018
Q1 | $122K | Buy |
1,926
+807
| +72% | +$48.2K | ﹤0.01% | 1488 |
|
|
2017
Q4 | $57K | Buy |
1,119
+405
| +57% | +$21.1K | ﹤0.01% | 1957 |
|
|
2017
Q3 | $37K | Hold |
714
| – | – | ﹤0.01% | 1990 |
|
|
2017
Q2 | $36K | Hold |
714
| – | – | ﹤0.01% | 1947 |
|
|
2017
Q1 | $32K | Hold |
714
| – | – | ﹤0.01% | 2066 |
|
|
2016
Q4 | $32K | Hold |
714
| – | – | ﹤0.01% | 2021 |
|
|
2016
Q3 | $29K | Buy |
714
+153
| +27% | +$6.5K | ﹤0.01% | 2028 |
|
|
2016
Q2 | $27K | Hold |
561
| – | – | ﹤0.01% | 1867 |
|
|
2016
Q1 | $24K | Hold |
561
| – | – | ﹤0.01% | 1901 |
|
|
2015
Q4 | $25K | Buy |
561
+292
| +109% | +$12.7K | ﹤0.01% | 1884 |
|
|
2015
Q3 | $13K | Buy |
269
+157
| +140% | +$8.62K | ﹤0.01% | 1726 |
|
|
2015
Q2 | $7K | Hold |
112
| – | – | ﹤0.01% | 1607 |
|
|
2015
Q1 | $6K | Buy |
+112
| New | +$5.49K | ﹤0.01% | 1707 |
|
Other funds holding CNMD
ICM
Zurich Cantonal Bank's CNMD Position: Q2 2026 in Review
Zurich Cantonal Bank held its CONMED (CNMD) position steady in Q2 2026 at 9,166 shares worth $300K. The position accounts for ﹤0.01% of the portfolio, ranked #2183.
Zurich Cantonal Bank first reported a position in CNMD in Q1 2015 and has held it in 45 quarters since. The position peaked at $746K in Q4 2023. 246 funds tracked by Wall St. Rank hold CNMD as of Q2 2026.
- Zurich Cantonal Bank held 9,166 shares of CONMED worth $300K as of Q2 2026.
- Zurich Cantonal Bank left its CONMED share count unchanged in Q2 2026.
- CONMED made up ﹤0.01% of Zurich Cantonal Bank's portfolio in Q2 2026, its #2183 holding.
- Zurich Cantonal Bank first reported a position in CONMED in Q1 2015 and has held it in 45 quarters since.
- Zurich Cantonal Bank's CONMED position peaked at $746K in Q4 2023.
- 246 funds tracked by Wall St. Rank held CONMED as of Q2 2026.
Based on Zurich Cantonal Bank's 13F filing for Q2 2026, filed 12 Aug 2026.